Differentiating Degenerative from Vascular Dementia with the Help of Optical Coherence Tomography Angiography Biomarkers.
Efthymios ChalkiasIoannis-Nikolaos ChalkiasChristos BakirtzisLambros MessinisGrigorios NasiosPanagiotis IoannidisDemetrios PirounidesPublished in: Healthcare (Basel, Switzerland) (2022)
Alzheimer's disease and vascular dementia account for the majority of cases of cognitive decline in elderly people. These two main forms of dementia, under which various subtypes fall, are often overlapping and, in some cases, definitive diagnosis may only be possible post-mortem. This has implications for the quality of care and the design of individualized interventions for these patients. Optical coherence tomography angiography (OCTA) is a non-invasive imaging modality used to visualize the retinal layers and vessels which shows encouraging results in the study of various neurological conditions, including dementia. This review aims to succinctly sum up the present state of knowledge and provide critical insight into emerging patterns of OCTA biomarker values in Alzheimer's disease and vascular dementia. According to the current literature, vessel density seems to be a common biomarker for both forms; inner retinal layer thickness might represent a biomarker preferentially affected in degenerative dementia including Alzheimer's, while, in contrast, the outer-layer thickness as a whole justifies attention as a potential vascular dementia biomarker. Radial peripapillary capillary density should also be further studied as a biomarker specifically linked to vascular dementia.
Keyphrases
- mild cognitive impairment
- cognitive decline
- cognitive impairment
- optical coherence tomography
- healthcare
- systematic review
- physical activity
- end stage renal disease
- magnetic resonance
- radiation therapy
- computed tomography
- high resolution
- risk assessment
- newly diagnosed
- peritoneal dialysis
- chronic pain
- optic nerve
- affordable care act